Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Hereditary Cancer in Clinical Practice
Published in: Hereditary Cancer in Clinical Practice 1/2007

Open Access 01-12-2007 | Erratum

Erratum to: Dear Readers

Author: Evgeny N. Imyanitov

Published in: Hereditary Cancer in Clinical Practice | Issue 1/2007

Login to get access

Excerpt

In the last issue of our journal, in the article BRCA1 4153delA founder mutation in Russian ovarian cancer patients written by Prof. Evgeny N. Imyanitov, the following errata apply. …
Metadata
Title
Erratum to: Dear Readers
Author
Evgeny N. Imyanitov
Publication date
01-12-2007
Publisher
BioMed Central
Published in
Hereditary Cancer in Clinical Practice / Issue 1/2007
Electronic ISSN: 1897-4287
DOI
https://doi.org/10.1186/1897-4287-5-1-56

Other articles of this Issue 1/2007

Hereditary Cancer in Clinical Practice 1/2007 Go to the issue

Research

ARLTS1 polymorphisms and basal cell carcinoma of the skin

Conference proceedings

Abstracts from the 10th Annual Meeting of the Collaborative Group of the Americas on Inherited Colorectal Cancer, November 9–10, 2006, Nashville, Tennessee, United States. Clinical Science Podium Presentations

Short report

Short report. The AIDIT and IMPACT conference 2006: Outcomes and future directions

Research

A hypothesis-generating search for new genetic breast cancer syndromes - a national study in 803 Swedish families

Research

Selected aspects of genetic counselling for BRCA1 mutation carriers
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits